ANN ARBOR, Mich., Oct. 24, 2017 -- Arotech Corporation (Nasdaq:ARTX) a provider of quality defense and security products for the military, law enforcement and homeland security markets, announced that it will release results for the quarter and nine months ended September 30, 2017, on Wednesday, November 8, 2017 after the market close.
Dean Krutty, acting Chief Executive Officer, and Tom Paup, Chief Financial Officer, will host a conference call on Thursday, November 9, 2017 at 9:00 a.m. Eastern time, to review the Company’s financial results and business outlook.
To participate, please call one of the following telephone numbers. Please dial in at least ten minutes before the start of the call:
U.S.: 1-888-567-1602
International: +1-404-267-0373
A telephonic playback of the conference call will be available by calling 1-877-481-4010 within the U.S. and +1-919-882-2331 internationally. The telephonic playback will be available beginning at 12:00 noon Eastern time on Thursday, November 9, 2017, and continue through 11:59 p.m. Eastern time on Thursday, November 16, 2017. The replay ID is 21455.
About Arotech Corporation
Arotech Corporation is a defense and security products and services company, engaged in two business areas: interactive simulation for military, law enforcement and commercial markets; and mobile power systems for the military, commercial and medical markets.
Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan, and research, development and production subsidiaries in Michigan, South Carolina, and Israel. For more information on Arotech, please visit Arotech’s website at www.arotech.com.
Investor Relations Contacts:
Scott Schmidt
Arotech Corporation
1-800-281-0356
[email protected]


xAI Cash Burn Highlights the High Cost of Competing in Generative AI
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Hyundai Motor Shares Surge on Nvidia Partnership Speculation
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Jollibee Plans U.S. Listing for International Business, Shares Rally
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 



